Why aren't I losing weight on Mounjaro?

Could you still be on a dose that hasn't reached therapeutic effect?

This is the question worth asking first. Mounjaro treatment begins at 2.5 mg, a dose whose main job is to settle your system and reduce early side effects, not to produce substantial fat loss. The tirzepatide prescribing schedule typically steps the dose upward every four weeks, through 5 mg, 7.5 mg and beyond, up to the 15 mg maintenance dose licensed in the UK. Most people see meaningful weight change only once they're established at mid-to-higher doses.

If you're two or three weeks into your first pen, the absence of dramatic results isn't a failure, it's the design. The NHS's patient information for tirzepatide confirms that weight loss typically becomes more pronounced as the dose increases. The real question to ask at this stage is whether your titration schedule is on track and whether you've been able to reach your highest tolerated dose. A prescriber can help clarify both.

If you've been at the same dose for several months and progress has stalled, that's a different conversation, and understanding why Mounjaro might not be working for you can help you figure out whether a dose increase is clinically appropriate or whether something else needs investigating.

Is the appetite effect being quietly undermined?

Mounjaro slows gastric emptying and raises satiety signals, but it doesn't override every eating pattern. A few things commonly cancel out the calorie reduction that should follow. Liquid calories are the biggest culprit: fruit juice, oat milk lattes, fizzy drinks and alcohol all add significant energy without triggering the fullness signals that solid food does. People on GLP-1 medicines often find their appetite for meals drops sharply, then underestimate how many calories they're still consuming through drinks.

Protein intake matters too. When the body is in a calorie deficit, it will burn muscle as well as fat unless protein is kept high enough to protect lean mass. Low protein also means hunger returns faster between doses. The practical guidance on getting the most from Mounjaro covers this in more detail, but the short version is: prioritise protein at every meal, keep processed snacks out of the house, and log what you drink.

It's also worth noting that ultra-processed foods (crisps, biscuits, highly palatable sweet or salty snacks) can override the satiety signalling that tirzepatide provides. The medicine makes it easier to eat less; it doesn't make poor food choices impossible.

What does a genuine weight-loss plateau actually mean?

A plateau is a period where weight stays flat for two to six weeks despite the medicine working and diet remaining consistent. It's real, it's frustrating, and it's also a well-documented part of the physiology of weight loss rather than a sign that treatment has failed. As body weight falls, the energy the body burns at rest also falls, so the same calorie intake that produced a deficit at the start produces a smaller one later.

NICE's appraisal of tirzepatide (TA1026) sets a clinical review threshold: if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing is worth re-evaluating. But a two-week flat patch at month three is not that scenario. The question of when weight loss naturally levels off on Mounjaro is worth reading if you're trying to distinguish a temporary stall from a genuine endpoint. Short answer: most people lose weight for the majority of the 72-week SURMOUNT-1 study period, though the rate slows in the latter months.

If you want to cost-compare your options or understand what a private prescription actually covers, the Mounjaro pricing page sets out what to expect from a transparent, all-inclusive service.

Are there biological factors working against you?

Tirzepatide is a powerful medicine, but it operates within a body that has its own competing signals. Three factors consistently slow weight loss and are frequently underestimated.

Sleep deprivation raises ghrelin (the hunger hormone) and lowers leptin (the fullness hormone), directly fighting the appetite suppression Mounjaro provides. Consistently poor sleep can stall weight loss even when the dose and diet are right. Similarly, chronic stress raises cortisol, which drives fat storage (particularly around the abdomen) and increases cravings for energy-dense foods.

Thyroid function is worth flagging to your GP if you have other symptoms of hypothyroidism (fatigue, feeling cold, constipation, hair loss). An underactive thyroid slows metabolism and blunts the response to almost any weight-loss intervention. It's not a common reason for Mounjaro not working, but it's one that's easily missed and easily treated once identified.

If you've been on Mounjaro for several months at a therapeutic dose and none of the above explains your stall, the right route is a prescriber conversation, not stopping treatment or switching without clinical guidance. Our team at nume reviews every repeat prescription individually, which means there's a natural checkpoint built in to catch exactly this kind of situation. If you haven't yet started treatment and are weighing up options, exploring the weight-loss treatments available is a good starting point.